Squarepoint’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $99.1K | Buy |
+10,744
| New | +$99.1K | ﹤0.01% | 2494 |
|
|
2025
Q1 | – | Sell |
-67,627
| Closed | -$726K | – | 2763 |
|
|
2024
Q4 | $726K | Buy |
67,627
+50,924
| +305% | +$547K | ﹤0.01% | 1727 |
|
|
2024
Q3 | $94.9K | Sell |
16,703
-28,649
| -63% | -$163K | ﹤0.01% | 2346 |
|
|
2024
Q2 | $191K | Buy |
+45,352
| New | +$191K | ﹤0.01% | 2153 |
|
|
2024
Q1 | – | Sell |
-23,403
| Closed | -$218K | – | 2437 |
|
|
2023
Q4 | $218K | Sell |
23,403
-18,667
| -44% | -$174K | ﹤0.01% | 2101 |
|
|
2023
Q3 | $276K | Buy |
42,070
+26,877
| +177% | +$176K | ﹤0.01% | 1971 |
|
|
2023
Q2 | $124K | Buy |
+15,193
| New | +$124K | ﹤0.01% | 2170 |
|
|
2023
Q1 | – | Sell |
-21,810
| Closed | -$202K | – | 2263 |
|
|
2022
Q4 | $202K | Buy |
21,810
+1,742
| +9% | +$16.1K | ﹤0.01% | 1888 |
|
|
2022
Q3 | $207K | Buy |
+20,068
| New | +$207K | ﹤0.01% | 1781 |
|
|
2022
Q1 | – | Sell |
-12,967
| Closed | -$225K | – | 2231 |
|
|
2021
Q4 | $225K | Sell |
12,967
-47,901
| -79% | -$831K | ﹤0.01% | 2019 |
|
|
2021
Q3 | $1.09M | Buy |
60,868
+20,249
| +50% | +$364K | ﹤0.01% | 1044 |
|
|
2021
Q2 | $929K | Buy |
40,619
+5,116
| +14% | +$117K | ﹤0.01% | 1226 |
|
|
2021
Q1 | $531K | Buy |
+35,503
| New | +$531K | ﹤0.01% | 1485 |
|
|
2020
Q4 | – | Sell |
-56,155
| Closed | -$256K | – | 2526 |
|
|
2020
Q3 | $256K | Buy |
+56,155
| New | +$256K | ﹤0.01% | 1796 |
|
|
2019
Q4 | – | Sell |
-12,631
| Closed | -$40K | – | 2376 |
|
|
2019
Q3 | $40K | Buy |
+12,631
| New | +$40K | ﹤0.01% | 2151 |
|
|
2018
Q1 | – | Sell |
-17,054
| Closed | -$55K | – | 1676 |
|
|
2017
Q4 | $55K | Buy |
+17,054
| New | +$55K | ﹤0.01% | 2000 |
|
|
2017
Q3 | – | Sell |
-14,400
| Closed | -$77K | – | 1590 |
|
|
2017
Q2 | $77K | Buy |
+14,400
| New | +$77K | ﹤0.01% | 1424 |
|
|
2016
Q4 | – | Sell |
-11,200
| Closed | -$41K | – | 1757 |
|
|
2016
Q3 | $41K | Buy |
+11,200
| New | +$41K | ﹤0.01% | 974 |
|
|
2016
Q2 | – | Sell |
-21,900
| Closed | -$107K | – | 1096 |
|
|
2016
Q1 | $107K | Buy |
+21,900
| New | +$107K | 0.01% | 1064 |
|